Literature DB >> 19370710

Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum.

Skyler P Dillon1, Anil D'Souza, Biji T Kurien, R Hal Scofield.   

Abstract

C1q is of interest in systemic lupus erythematosus (SLE) research due to deficiencies in its activity being associated with the disease. Current published protocols for measuring C1q vary greatly in their results and ease of reproducibility. Due to this, average C1q concentrations have been reported between 56 and 276 microg/mL in non-SLE serum. We present an improved method for quantifying C1q concentrations, which employs a sandwich ELISA. This method has improved precision, cost efficiency, up-scaling, reproducibility, and uses significantly lesser volumes of serum sample when compared to RID and other methods for quantifying C1q. We report an average concentration of 113 +/- 40 microg/mL for C1q in non-SLE serum. The assay designed here will be useful in the high-throughput measurement of serum C1q in SLE cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370710      PMCID: PMC2829988          DOI: 10.1002/biot.200800273

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  17 in total

1.  Evaluation of seven commercial ELISA kits compared with the C1q solid-phase binding RIA for detection of circulating immune complexes.

Authors:  E Van Hoeyveld; X Bossuyt
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

Review 2.  Systemic lupus erythematosus, complement deficiency, and apoptosis.

Authors:  M C Pickering; M Botto; P R Taylor; P J Lachmann; M J Walport
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

3.  High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients.

Authors:  L Horváth; L Czirják; B Fekete; L Jakab; T Pozsonyi; L Kalabay; L Romics; K Miklós; L Varga; Z Prohászka; A Szakács; E Nagy; M R Daha; G Füst
Journal:  Clin Exp Rheumatol       Date:  2001 Nov-Dec       Impact factor: 4.473

4.  C1q complement component and -antibodies reflect SLE activity and kidney involvement.

Authors:  P Horák; Z Hermanová; J Zadrazil; H Ciferská; M Ordeltová; L Kusá; M Zurek; T Tichý
Journal:  Clin Rheumatol       Date:  2005-11-26       Impact factor: 2.980

5.  Pediatric systemic lupus erythematosus with C1q deficiency.

Authors:  Maryam Kallel-Sellami; Lilia Baili-Klila; Yousr Zerzeri; Lilia Laadhar; Jacques Blouin; Mohamed Slim Abdelmoula; Mondher Zitouni; Véronique Fremeaux-Bacchi; Marie France Ben Dridi; Sondes Makni
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

6.  High-density lipoprotein apolipoproteins in urine: II. Enzyme-linked immunoassay of apolipoprotein A-I.

Authors:  Z A Gomo; L O Henderson
Journal:  Clin Chem       Date:  1988-09       Impact factor: 8.327

7.  Familial C1q deficiency associated with renal and cutaneous disease.

Authors:  F Leyva-Cobián; I Moneo; F Mampaso; M Sánchez-Bayle; J L Ecija; A Bootello
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

8.  Determination in the nanogram range of C1q in serum and unconcentrated CSF by electro-immunodiffusion.

Authors:  E Schuller; M Helary
Journal:  J Immunol Methods       Date:  1983-01-28       Impact factor: 2.303

9.  Low molecular weight C1q in systemic lupus erythematosus.

Authors:  R Hoekzema; A J Hannema; T J Swaak; J Paardekooper; C E Hack
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

Review 10.  C1q, autoimmunity and apoptosis.

Authors:  Marina Botto; Mark J Walport
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

View more
  16 in total

1.  Identification of novel coding mutation in C1qA gene in an African-American pedigree with lupus and C1q deficiency.

Authors:  B Namjou; M Keddache; D Fletcher; S Dillon; L Kottyan; G Wiley; P M Gaffney; B E Wakeland; C Liang; E K Wakeland; R H Scofield; K Kaufman; J B Harley
Journal:  Lupus       Date:  2012-04-03       Impact factor: 2.911

2.  Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.

Authors:  Lee Aun Tan; Andrew C Yang; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2011-05-15       Impact factor: 14.870

3.  Prolidase deficiency breaks tolerance to lupus-associated antigens.

Authors:  Biji T Kurien; Anil D'Sousa; Benjamin F Bruner; Timothy Gross; Judith A James; Ira N Targoff; Jacen S Maier-Moore; Isaac T W Harley; Heng Wang; R Hal Scofield
Journal:  Int J Rheum Dis       Date:  2013-12-14       Impact factor: 2.454

4.  Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells.

Authors:  J William Lindsey; Sandeep K Agarwal; Filemon K Tan
Journal:  Mol Med       Date:  2010-09-17       Impact factor: 6.354

5.  Complement activation by phospholipids: the interplay of factor H and C1q.

Authors:  Lee Aun Tan; Bingbin Yu; Francis C J Sim; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

6.  Complement activation by human IgG antibodies to galactose-α-1,3-galactose.

Authors:  Jens Magnus Bernth Jensen; Nick Stub Laursen; Rasmus Kjeldsen Jensen; Gregers Rom Andersen; Jens Christian Jensenius; Uffe B Skov Sørensen; Steffen Thiel
Journal:  Immunology       Date:  2020-07-14       Impact factor: 7.397

7.  Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells.

Authors:  Marie E Benoit; Elizabeth V Clarke; Pedro Morgado; Deborah A Fraser; Andrea J Tenner
Journal:  J Immunol       Date:  2012-04-20       Impact factor: 5.422

8.  C1q and HMGB1 reciprocally regulate human macrophage polarization.

Authors:  Myoungsun Son; Amit Porat; Mingzhu He; Jolien Suurmond; Frances Santiago-Schwarz; Ulf Andersson; Thomas R Coleman; Bruce T Volpe; Kevin J Tracey; Yousef Al-Abed; Betty Diamond
Journal:  Blood       Date:  2016-09-28       Impact factor: 22.113

9.  Complete complement deficiency in a large cohort of familial systemic lupus erythematosus.

Authors:  R Aggarwal; A L Sestak; A D'Souza; A D'Sousa; S P Dillon; B Namjou; R H Scofield
Journal:  Lupus       Date:  2009-11-12       Impact factor: 2.911

10.  Cell surface expression and function of the macromolecular c1 complex on the surface of human monocytes.

Authors:  Kinga K Hosszu; Alisa Valentino; Yan Ji; Mara Matkovic; Lina Pednekar; Nina Rehage; Nithin Tumma; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Front Immunol       Date:  2012-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.